Age-related inflammatory damage may have found an unexpected metabolic brake. The discovery that phosphoenolpyruvate (PEP), a common cellular energy intermediate, actively suppresses inflammatory pathways challenges assumptions about how our bodies naturally regulate aging-related tissue damage. This metabolic connection to inflammation control could reshape approaches to healthy aging interventions.
PEP directly inhibits the cGAS-STING pathway, a cellular alarm system that triggers inflammation when it detects damaged DNA or cellular debris. In Alzheimer's disease mouse models, elevated PEP levels reduced neuroinflammation and improved cognitive performance. Human data revealed correlations between higher PEP concentrations and healthier aging markers across multiple physiological systems. The research demonstrates that this glycolytic intermediate functions beyond energy metabolism, serving as an endogenous anti-inflammatory regulator.
This finding bridges two critical aging research domains: metabolic dysfunction and chronic inflammation. The cGAS-STING pathway becomes hyperactive with age, contributing to the persistent low-grade inflammation that accelerates tissue deterioration. PEP's inhibitory effect suggests that maintaining robust glucose metabolism may provide natural protection against inflammatory aging. However, the mechanism raises important questions about metabolic trade-offs. PEP is essential for energy production, so its dual role as an inflammatory brake creates potential competing demands. The research also relied heavily on mouse models, requiring validation in human aging cohorts. While promising, translating these insights into interventions will require understanding how to optimize PEP levels without disrupting cellular energy balance. This represents solid mechanistic progress in aging biology rather than an immediate therapeutic breakthrough.
